| Dr James B Gerstner, MD | |
|
8940 N Wood Sage Rd, Peoria, IL 61615-7822 | |
| (309) 243-3000 | |
| (309) 243-3050 |
| Full Name | Dr James B Gerstner |
|---|---|
| Gender | Male |
| Speciality | Internal Medicine - Hematology & Oncology |
| Location | 8940 N Wood Sage Rd, Peoria, Illinois |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1285633503 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RH0003X | Internal Medicine - Hematology & Oncology | (Illinois) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Dr James B Gerstner, MD 8940 N Wood Sage Rd, Peoria, IL 61615-7822 Ph: (309) 243-3000 | Dr James B Gerstner, MD 8940 N Wood Sage Rd, Peoria, IL 61615-7822 Ph: (309) 243-3000 |
News Archive
Efforts by Republican lawmakers to scale back Medicaid enrollment could undercut an aspect of the program that has widespread bipartisan appeal — covering more children, research published Tuesday in the journal Health Affairs suggests.
Oxford BioDynamics Plc, a biotechnology company focused on the discovery and development of epigenetic biomarkers based on regulatory genome architecture, for use within the pharmaceutical and biotechnology industry, presented its latest results at the annual meeting of the Foundation for National Institute for Health Biomarker Consortium Cancer Steering Committee, held in Washington, DC on 6-7 November 2017.
Significant progress has been made in several low- and middle-income countries in increasing access to HIV/AIDS services, according to a new report released today. The report Towards universal access by WHO, the United Nations Children's Fund and the Joint United Nations Programme on HIV/AIDS is the fourth annual report for tracking progress made in achieving the 2010 target of providing universal access to HIV prevention, treatment and care.
Neurocrine Biosciences, Inc. today announced results from the open-label portion of the six month Phase II Daisy PETAL study (901 study) using its proprietary, orally-active nonpeptide Gonadotropin-Releasing Hormone (GnRH) receptor antagonist, elagolix, in patients with endometriosis.
A molecular signature that helps account for the aggressive behavior of a variety of cancers such as pancreatic, breast and melanoma may also predict the likelihood of successful treatment with a particular anti-cancer drug. The finding, which could lead to a personalized approach to treatment for a variety of solid tumors that are currently resistant to therapies, will be published September 6 in the advance online edition of Nature Medicine.
› Verified 9 days ago
Sandeep Banga, M.D. Hematology & Oncology Medicare: Not Enrolled in Medicare Practice Location: 530 Ne Glen Oak Ave, Peoria, IL 61637 Phone: 309-655-6384 Fax: 309-655-7732 | |
Riaz Shah, MD Hematology & Oncology Medicare: May Accept Medicare Assignments Practice Location: 221 Ne Glen Oak Ave, Suite 504, Peoria, IL 61636 Phone: 309-672-5729 | |
Dr. James Daniel Dewar, D.O. Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 530 Ne Glen Oak Ave, Peoria, IL 61637 Phone: 309-655-7257 | |
Waqas Ali, MD Hematology & Oncology Medicare: Not Enrolled in Medicare Practice Location: 221 Ne Glen Oak Ave, Peoria, IL 61636 Phone: 309-672-5522 | |
Dr. Sudhir Mungee, MD Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 5405 North Knoxville Avenue, Peoria, IL 61614 Phone: 309-691-4410 Fax: 309-589-2830 | |
Dr. Nikesh Kavi Patel, MD Hematology & Oncology Medicare: Not Enrolled in Medicare Practice Location: 530 Ne Glen Oak Ave, Peoria, IL 61637 Phone: 309-655-6384 Fax: 309-655-7732 | |
Dr. Bhanu T Paturi, M.D Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 5105 N Glen Park Place Rd, Peoria, IL 61614 Phone: 309-683-8383 |